Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 15 studies | 53% ± 15% | |
| macrophage | 11 studies | 34% ± 13% | |
| astrocyte | 9 studies | 30% ± 17% | |
| oligodendrocyte precursor cell | 9 studies | 26% ± 5% | |
| endothelial cell | 8 studies | 31% ± 11% | |
| GABAergic neuron | 7 studies | 43% ± 17% | |
| glutamatergic neuron | 6 studies | 44% ± 24% | |
| dendritic cell | 6 studies | 28% ± 6% | |
| epithelial cell | 6 studies | 29% ± 8% | |
| Mueller cell | 6 studies | 44% ± 20% | |
| monocyte | 6 studies | 33% ± 15% | |
| fibroblast | 6 studies | 23% ± 4% | |
| myeloid cell | 5 studies | 28% ± 14% | |
| smooth muscle cell | 5 studies | 28% ± 11% | |
| pericyte | 5 studies | 29% ± 6% | |
| interneuron | 5 studies | 36% ± 12% | |
| adipocyte | 4 studies | 29% ± 2% | |
| alveolar macrophage | 4 studies | 47% ± 16% | |
| endothelial cell of lymphatic vessel | 4 studies | 22% ± 1% | |
| neural progenitor cell | 3 studies | 32% ± 16% | |
| B cell | 3 studies | 22% ± 4% | |
| ciliated cell | 3 studies | 24% ± 8% | |
| transit amplifying cell | 3 studies | 34% ± 21% | |
| microglial cell | 3 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2278.44 | 2636 / 2642 | 98% | 29.12 | 689 / 705 |
| intestine | 100% | 2032.77 | 963 / 966 | 97% | 13.85 | 510 / 527 |
| ovary | 100% | 5712.82 | 180 / 180 | 96% | 15.15 | 414 / 430 |
| stomach | 100% | 1217.37 | 358 / 359 | 95% | 15.59 | 271 / 286 |
| kidney | 100% | 1138.57 | 89 / 89 | 94% | 18.56 | 850 / 901 |
| esophagus | 100% | 996.22 | 1440 / 1445 | 92% | 13.69 | 168 / 183 |
| uterus | 100% | 2685.01 | 170 / 170 | 86% | 11.01 | 397 / 459 |
| pancreas | 94% | 633.25 | 308 / 328 | 92% | 11.07 | 164 / 178 |
| lung | 100% | 1530.58 | 576 / 578 | 85% | 8.81 | 976 / 1155 |
| thymus | 100% | 1611.64 | 653 / 653 | 82% | 6.93 | 498 / 605 |
| bladder | 100% | 1121.95 | 21 / 21 | 72% | 7.99 | 363 / 504 |
| breast | 100% | 1975.49 | 459 / 459 | 64% | 5.81 | 720 / 1118 |
| skin | 76% | 1166.79 | 1382 / 1809 | 75% | 9.51 | 354 / 472 |
| prostate | 97% | 781.07 | 238 / 245 | 35% | 1.57 | 176 / 502 |
| adrenal gland | 74% | 344.99 | 191 / 258 | 46% | 2.80 | 106 / 230 |
| eye | 0% | 0 | 0 / 0 | 100% | 25.13 | 80 / 80 |
| spleen | 100% | 1587.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1473.99 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1394.56 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 15.03 | 43 / 45 |
| muscle | 88% | 1085.80 | 706 / 803 | 0% | 0 | 0 / 0 |
| liver | 11% | 40.63 | 25 / 226 | 45% | 4.61 | 181 / 406 |
| heart | 37% | 162.43 | 319 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 34% | 2.19 | 10 / 29 |
| peripheral blood | 21% | 115.41 | 197 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0001934 | Biological process | positive regulation of protein phosphorylation |
| GO_0035330 | Biological process | regulation of hippo signaling |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0030295 | Molecular function | protein kinase activator activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | MOB3B |
| Protein name | MOB kinase activator 3B (Mob1 homolog 2b) (Mps one binder kinase activator-like 2B) (MOB kinase activator-like 2B) |
| Synonyms | C9orf35 MOBKL2B |
| Description | FUNCTION: Modulates LATS1 expression in the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. . |
| Accessions | ENST00000262244.6 Q86TA1 |